Skip to main content

Table 1 Baseline clinical characteristics of the patients

From: Effect of carvedilol on premature ventricular complexes originating from the ventricular outflow tract

 

Overall (n = 25)

Age (years)

54.9 ± 13.9

Male

8 (32%)

Hypertension

7 (28%)

Diabetes mellitus

2 (8%)

Creatinine (mg/dL)

0.74 ± 0.16

LV EF (%)

64.5 ± 5.0

LA volume (mm3)

60.4 ± 20.3

Dose of Dilatrend SR® (mg)

18.2 ± 10.2

Duration of treatment (days)

158.3 ± 92

  1. Values are presented as n (%) or mean ± standard deviation
  2. EF ejection fraction, LA left atrium, Dilatrend SR® sustained release formulation of carvedilol, PVC premature ventricular complexes
Back to article page

International Journal of Arrhythmia

ISSN: 2466-1171

Contact us